Skip to Content

Q200 (Quetiapine Fumarate Extended-Release 200 mg)

Pill with imprint Q200 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by Mallinckrodt Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Q200

Quetiapine Fumarate Extended-Release

Imprint
Q200
Strength
200 mg
Color
Yellow
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mallinckrodt Inc.
National Drug Code (NDC)
00406-1182
Inactive Ingredients
lactose anhydrous, ethylcellulose (100 mPa.s), microcrystalline cellulose, hydroxyethyl cellulose (4000 mpa.s at 1%), magnesium stearate, titanium dioxide, triacetin, polydextrose, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.